Skip to main content
. 2012 Mar 1;4(2):274–280. doi: 10.4161/mabs.4.2.19253

Table 5.

State of the art antibody production methods and their dependence on Cabilly II and III

Production method Company Patent Protected by Cabilly II? Protected by Cabilly III?
Heterologous Dimeric Protein Production in Heterokaryons Neugenesis graphic file with name mabs0402_0274_fig012.jpg US5643745 No, because two cell lines are independently transformed with HC DNA and LC DNA, and are then fused Probably yes
Milk secretion in transgenic mammals GTC Biotherapeutics graphic file with name mabs0402_0274_fig013.jpg US5827690 No, because transgenic animal comprises a full repertoire of heavy and LC genes, i.e. no transformation of a host cell, and expression takes place in hybridoma cells No, because no recombinant host cells (cells which have been transformed with vectors used)
Hybridoma cells obtained from transgenic rodents or mice Regeneron VelocImmune graphic file with name mabs0402_0274_fig014.jpg US7105348
Expression of monoclonal antibodies in ciliate host cells with different mating types Cilian AG graphic file with name mabs0402_0274_fig015.jpg WO2011107520 No, because two cells which have been trasformed with HC and Lc, respectively, can be conjugated to express full antibody Probably yes